Translational Psychiatry

Article	Citations
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease	263
Mapping global prevalence of depression among postpartum women	259
Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review	203
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder	156
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer’s disease	155
Psycho-social factors associated with mental resilience in the Corona lockdown	134
Public mental health problems during COVID-19 pandemic: a large-scale meta-analysis of the evidence	117
How machine-learning recommendations influence clinician treatment selections: the example of antidepressant selection	109
Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype?	107
Depression, anxiety and associated factors among Chinese adolescents during the COVID-19 outbreak: a comparison of two cross-sectional studies	102
Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression	91
Oxidative stress marker aberrations in children with autism spectrum disorder: a systematic review and meta-analysis of 87 studies (N = 9109)	89
Mild behavioral impairment and its relation to tau pathology in preclinical Alzheimer’s disease	88
Mental disorders following COVID-19 and other epidemics: a systematic review and meta-analysis	87
The effects of social isolation stress and discrimination on mental health	85
A systematic review of childhood maltreatment and DNA methylation: candidate gene and epigenome-wide approaches	84
Antidepressants fluoxetine and amitriptyline induce alterations in intestinal microbiota and gut microbiome function in rats exposed to chronic unpredictable mild stress	84
Impact of COVID-19 lockdown on mental health in Germany: longitudinal observation of different mental health trajectories and protective factors	83
Role of diet and its effects on the gut microbiome in the pathophysiology of mental disorders	82
Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review	81
Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a randomized controlled trial	76
Altered resting-state functional connectome in major depressive disorder: a mega-analysis from the PsyMRI consortium	74
The association between depression and metabolic syndrome and its components: a bidirectional two-sample Mendelian randomization study	73
Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes	71
Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation	70

COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study	69
Gut microbiota link dietary fiber intake and short-chain fatty acid metabolism with eating behavior	69
Probiotics-induced changes in gut microbial composition and its effects on cognitive performance after stress: exploratory analyses	64
Sleep in Alzheimer’s disease: a systematic review and meta-analysis of polysomnographic findings	64
Neuroinflammation in schizophrenia: the role of nuclear factor kappa B	63
Transdiagnostic dimensions of psychopathology explain individuals’ unique deviations from normative neurodevelopment in brain structure	63
Biallelic mutations in the death domain of PIDD1 impair caspase-2 activation and are associated with intellectual disability	62
A randomised, double-blind, sham-controlled trial of deep brain stimulation of the bed nucleus of the stria terminalis for treatment-resistant obsessive-compulsive disorder	60
Parental characteristics and offspring mental health and related outcomes: a systematic review of genetically informative literature	60
Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents	60
Early life adversity shapes neural circuit function during sensitive postnatal developmental periods	59
Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors	59
Gray and white matter morphology in substance use disorders: a neuroimaging systematic review and meta-analysis	59
Characterization of gut microbiome in mice model of depression with divergent response to escitalopram treatment	58
Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys	58
“GrimAge,” an epigenetic predictor of mortality, is accelerated in major depressive disorder	58
Glutamate and microglia activation as a driver of dendritic apoptosis: a core pathophysiological mechanism to understand schizophrenia	57
Personalized machine learning of depressed mood using wearables	57
Psychological and biological resilience modulates the effects of stress on epigenetic aging	56
Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19	56
Network analysis of depressive and anxiety symptoms in adolescents during the later stage of the COVID-19 pandemic	56
Establishing a clinical service to prevent psychosis: What, how and when? Systematic review	55
Spontaneous and deliberate creative cognition during and after psilocybin exposure	55
Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression	55
From mechanisms to markers: novel noninvasive EEG proxy markers of the neural excitation and inhibition system in humans	54
Melatonin’s neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders	54
Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder	54
A diet high in sugar and fat influences neurotransmitter metabolism and then affects brain function by altering the gut microbiota	54
Mindfulness practice for protecting mental health during the COVID-19 pandemic	54
Integrative analysis of genome-wide association studies identifies novel loci associated with neuropsychiatric disorders	54
Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study	53
Network analysis of depressive symptoms in Hong Kong residents during the COVID-19 pandemic	53
Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder	53
Immunological causes of obsessive-compulsive disorder: is it time for the concept of an “autoimmune OCD” subtype?	53
Reducing intrusive memories after trauma via a brief cognitive task intervention in the hospital emergency department: an exploratory pilot randomised controlled trial	53
Efficacy and tolerability of repetitive transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis	52
Neurosteroid allopregnanolone (3α,5α-THP) inhibits inflammatory signals induced by activated MyD88-dependent toll-like receptors	52
The association of clinical correlates, metabolic parameters, and thyroid hormones with suicide attempts in first-episode and drug-naïve patients with major depressive disorder comorbid with anxiety:	52
Socioeconomic status, BMI, and brain development in children	51
Proteomics analysis of the gut–brain axis in a gut microbiota-dysbiosis model of depression	51
The role of the immune system in posttraumatic stress disorder	51
Gut microbial taxa elevated by dietary sugar disrupt memory function	51
Late-life depression and increased risk of dementia: a longitudinal cohort study	51
Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression	50
The effects of early life adversity on children’s mental health and cognitive functioning	50
Structural and functional deficits and couplings in the cortico-striato-thalamo-cerebellar circuitry in social anxiety disorder	50
Consolidation/reconsolidation therapies for the prevention and treatment of PTSD and re-experiencing: a systematic review and meta-analysis	50
Default mode and salience network alterations in suicidal and non-suicidal self-injurious thoughts and behaviors in adolescents with depression	49
Comorbidities in autism spectrum disorder and their etiologies	49
Insulinopathies of the brain? Genetic overlap between somatic insulin-related and neuropsychiatric disorders	48

Glutamatergic dysfunction in Schizophrenia	47
Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder	47
Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy	47
Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers	47
Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms	46
A schizophrenia subgroup with elevated inflammation displays reduced microglia, increased peripheral immune cell and altered neurogenesis marker gene expression in the subependymal zone	46
COVID-19 restrictions and age-specific mental health—U.S. probability-based panel evidence	46
Theta burst stimulation for the acute treatment of major depressive disorder: A systematic review and meta-analysis	46
Ibudilast, a neuroimmune modulator, reduces heavy drinking and alcohol cue-elicited neural activation: a randomized trial	46
Serum d-serine levels are altered in early phases of Alzheimer’s disease: towards a precocious biomarker	45
Fronto-limbic neural variability as a transdiagnostic correlate of emotion dysregulation	45
Compassion toward others and self-compassion predict mental and physical well-being: a 5-year longitudinal study of 1090 community-dwelling adults across the lifespan	45
A machine learning algorithm to differentiate bipolar disorder from major depressive disorder using an online mental health questionnaire and blood biomarker data	44
Amyloid-beta uptake by blood monocytes is reduced with ageing and Alzheimer’s disease	44
Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report	44
Anomalous brain gyrification patterns in major psychiatric disorders: a systematic review and transdiagnostic integration	44
Mechanisms of neuroplasticity linking early adversity to depression: developmental considerations	44
Transcription factor 4 and its association with psychiatric disorders	44
Neural contributors to trauma resilience: a review of longitudinal neuroimaging studies	43
The IL-6 antagonist tocilizumab is associated with worse depression and related symptoms in the medically ill	42
Predicting treatment response using EEG in major depressive disorder: A machine-learning meta-analysis	42
Title: “Labels Matter: Is it stress or is it Trauma?”	42
The patterns of family genetic risk scores for eleven major psychiatric and substance use disorders in a Swedish national sample	42
Anxiety and depressive symptoms in college students during the late stage of the COVID-19 outbreak: a network approach	41
Transcriptome-wide association study identifies new susceptibility genes and pathways for depression	41
Social support mediates the influence of cerebellum functional connectivity strength on postpartum depression and postpartum depression with anxiety	41
Magnetic resonance imaging for individual prediction of treatment response in major depressive disorder: a systematic review and meta-analysis	40
Anomaly detection to predict relapse risk in schizophrenia	40
Ethnic and trans-ethnic genome-wide association studies identify new loci influencing Japanese Alzheimer’s disease risk	40
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder	40
Sensory over-responsivity is related to GABAergic inhibition in thalamocortical circuits	40
Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data	40
Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease	39
Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions	39
MicroRNA-dependent control of neuroplasticity in affective disorders	39
Cortical structure and the risk for Alzheimer’s disease: a bidirectional Mendelian randomization study	39
Brain network dysfunctions in addiction: a meta-analysis of resting-state functional connectivity	39
Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia	39
Emerging behavioral and neuroimaging biomarkers for early and accurate characterization of autism spectrum disorders: a systematic review	38
Mental health and music engagement: review, framework, and guidelines for future studies	38
Natural Language Processing markers in first episode psychosis and people at clinical high-risk	38
Decentering as a core component in the psychological treatment and prevention of youth anxiety and depression: a narrative review and insight report	38
Cannabis, schizophrenia genetic risk, and psychotic experiences: a cross-sectional study of 109,308 participants from the UK Biobank	38
Genome-wide DNA methylation and gene expression analyses in monozygotic twins identify potential biomarkers of depression	37
Proteomics of autism and Alzheimer’s mouse models reveal common alterations in mTOR signaling pathway	37
Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study	37
Genetic association study of childhood aggression across raters, instruments, and age	37
Sex differences in the neuroanatomy of alcohol dependence: hippocampus and amygdala subregions in a sample of 966 people from the ENIGMA Addiction Working Group	37
Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis	37
Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders	37
Maternal immune activation induces autism-like changes in behavior, neuroinflammatory profile and gut microbiota in mouse offspring of both sexes	36
Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study	36
Brain structural correlates of insomnia severity in 1053 individuals with major depressive disorder: results from the ENIGMA MDD Working Group	36
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status	36
Contributing factors to advanced brain aging in depression and anxiety disorders	36
Cell-type-specific epigenetic effects of early life stress on the brain	36
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients	36
Brain dynamics: the temporal variability of connectivity, and differences in schizophrenia and ADHD	36
Global prevalence of mild cognitive impairment among older adults living in nursing homes: a meta-analysis and systematic review of epidemiological surveys	35
The gut microbiome in social anxiety disorder: evidence of altered composition and function	35
A simultaneous [11C]raclopride positron emission tomography and functional magnetic resonance imaging investigation of striatal dopamine binding in autism	35
Thalamocortical connectivity is associated with autism symptoms in high-functioning adults with autism and typically developing adults	35
Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder	35
Intensification of functional neural control on heartbeat dynamics in subclinical depression	35
Cortisol and inflammatory biomarker levels in youths with attention deficit hyperactivity disorder (ADHD): evidence from a systematic review with meta-analysis	35
Childhood maltreatment predicts subsequent anxiety symptoms among Chinese adolescents: the role of the tendency of coping styles	35
Beyond antipsychotics: a twenty-first century update for preclinical development of schizophrenia therapeutics	35
Neural network of bipolar disorder: Toward integration of neuroimaging and neurocircuit-based treatment strategies	35
Role of dietary factors in the prevention and treatment for depression: an umbrella review of meta-analyses of prospective studies	35
Functional network alterations differently associated with suicidal ideas and acts in depressed patients: an indirect support to the transition model	34
Glycosylation and behavioral symptoms in neurological disorders	34
Nuclear factor of activated T cells 4 in the prefrontal cortex is required for prophylactic actions of (R)-ketamine	34
A pilot exploration of multi-omics research of gut microbiome in major depressive disorders	34
Obesity and atypical depression symptoms: findings from Mendelian randomization in two European cohorts	34
Exposure to maternal high-fat diet induces extensive changes in the brain of adult offspring	34
White matter microstructure and its relation to clinical features of obsessive–compulsive disorder: findings from the ENIGMA OCD Working Group	34
Acute psychological impact on COVID-19 patients in Hubei: a multicenter observational study	34
The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic	33
Cortical and subcortical brain structure in generalized anxiety disorder: findings from 28 research sites in the ENIGMA-Anxiety Working Group	33
The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imagi	33

Polygenic overlap and shared genetic loci between loneliness, severe mental disorders, and cardiovascular disease risk factors suggest shared molecular mechanisms	33
The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia	33
Genetics of autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses	33
Drug addiction: from bench to bedside	33
Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice	33
Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study	33
Psychobiotic interventions for anxiety in young people: a systematic review and meta-analysis, with youth consultation	32
Intraoperative neural signals predict rapid antidepressant effects of deep brain stimulation	32
Cell-type-specific expression quantitative trait loci associated with Alzheimer disease in blood and brain tissue	32
Enhanced long-term potentiation and impaired learning in mice lacking alternative exon 33 of CaV1.2 calcium channel	32
The proteomic architecture of schizophrenia iPSC-derived cerebral organoids reveals alterations in GWAS and neuronal development factors	32
Prevalence and correlates of suicidal ideation and suicide attempts in preadolescent children: A US population-based study	32
Exploratory drive, fear, and anxiety are dissociable and independent components in foraging mice	32
Prenatal androgen exposure causes a sexually dimorphic transgenerational increase in offspring susceptibility to anxiety disorders	32
Prevalence of poor psychiatric status and sleep quality among frontline healthcare workers during and after the COVID-19 outbreak: a longitudinal study	31
Insula sub-regions across the psychosis spectrum: morphology and clinical correlates	31
Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis	31
Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis	31
The self on its axis: a framework for understanding depression	31
Excitatory/inhibitory imbalance in autism: the role of glutamate and GABA gene-sets in symptoms and cortical brain structure	31
Prevalence of and factors associated with post-traumatic stress disorder among French university students 1 month after the COVID-19 lockdown	31
Default-mode and fronto-parietal network connectivity during rest distinguishes asymptomatic patients with bipolar disorder and major depressive disorder	31
Bilateral Habenula deep brain stimulation for treatment-resistant depression: clinical findings and electrophysiological features	31
Zbtb16 regulates social cognitive behaviors and neocortical development	31
The role of the orbitofrontal cortex and the nucleus accumbens for craving in alcohol use disorder	30
Beneficial effects of running exercise on hippocampal microglia and neuroinflammation in chronic unpredictable stress-induced depression model rats	30
Early-life stress lastingly impacts microglial transcriptome and function under basal and immune-challenged conditions	30
Conducting double-blind placebo-controlled clinical trials of transcranial alternating current stimulation (tACS)	30
Neural substrates of reward anticipation and outcome in schizophrenia: a meta-analysis of fMRI findings in the monetary incentive delay task	29
Psychiatric symptoms and behavioral adjustment during the COVID-19 pandemic: evidence from two population-representative cohorts	29
Deficits in hippocampal-dependent memory across different rodent models of early life stress: systematic review and meta-analysis	29
Cross-tissue correlations of genome-wide DNA methylation in Japanese live human brain and blood, saliva, and buccal epithelial tissues	29
DNA methylation differences associated with social anxiety disorder and early life adversity	28
Natural language processing for mental health interventions: a systematic review and research framework	28
Correction: Mapping global prevalence of depression among postpartum women	28
Serotonin depletion amplifies distinct human social emotions as a function of individual differences in personality	28
Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response	28
Exploration of alcohol use disorder-associated brain miRNA–mRNA regulatory networks	28
Circulating endocannabinoids and genetic polymorphisms as predictors of posttraumatic stress disorder symptom severity: heterogeneity in a community-based cohort	28
Emerging imaging methods to study whole-brain function in rodent models	28
Virtual reality: a powerful technology to provide novel insight into treatment mechanisms of addiction	28
Region-specific elevations of glutamate + glutamine correlate with the sensory symptoms of autism spectrum disorders	28
Biological factors influencing depression in later life: role of aging processes and treatment implications	28
Reduced nucleus accumbens functional connectivity in reward network and default mode network in patients with recurrent major depressive disorder	28
Understanding complex functional wiring patterns in major depressive disorder through brain functional connectome	28
Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial	28
Human forebrain organoids reveal connections between valproic acid exposure and autism risk	27
ECT-induced cognitive side effects are associated with hippocampal enlargement	27
Obsessive–compulsive symptoms and information seeking during the Covid-19 pandemic	27
How do established developmental risk-factors for schizophrenia change the way the brain develops?	27
Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants	27
Synaptic processes and immune-related pathways implicated in Tourette syndrome	27
The association between latent trauma and brain structure in children	27
A review of functional and structural neuroimaging studies to investigate the inner speech model of auditory verbal hallucinations in schizophrenia	27
Effects of pharmacological treatment on metabolomic alterations in animal models of depression	27
Chronic mild stress-induced protein dysregulations correlated with susceptibility and resiliency to depression or anxiety revealed by quantitative proteomics of the rat prefrontal cortex	27
Digital phenotyping of generalized anxiety disorder: using artificial intelligence to accurately predict symptom severity using wearable sensors in daily life	27
Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study	27
Understanding the psychiatric symptoms of COVID-19: a meta-analysis of studies assessing psychiatric symptoms in Chinese patients with and survivors of COVID-19 and SARS by using the Symptom Checklist	27
Reward and aversion encoding in the lateral habenula for innate and learned behaviours	27
Evidence for similar structural brain anomalies in youth and adult attention-deficit/hyperactivity disorder: a machine learning analysis	27
Genome-wide association study of pediatric obsessive-compulsive traits: shared genetic risk between traits and disorder	27
CD36 deficiency affects depressive-like behaviors possibly by modifying gut microbiota and the inflammasome pathway in mice	26
Alcohol use disorder causes global changes in splicing in the human brain	26
Predicting alcohol use disorder remission: a longitudinal multimodal multi-featured machine learning approach	26
Altered relationship between subjective perception and central representation of touch hedonics in adolescents with autism-spectrum disorder	26
Effect of TAAR1/5-HT1A agonist SEP-363856 on REM sleep in humans	26
Translational opportunities in animal and human models to study alcohol use disorder	26
Cell-type specific changes in PKC-delta neurons of the central amygdala during alcohol withdrawal	26
Transcranial direct current stimulation induces long-term potentiation-like plasticity in the human visual cortex	26
Combined effects of genotype and childhood adversity shape variability of DNA methylation across age	26
1q21.1 distal copy number variants are associated with cerebral and cognitive alterations in humans	26
The hidden link between circadian entropy and mental health disorders	26
Plasma neurofilament light as a potential biomarker for cognitive decline in a longitudinal study of middle-aged urban adults	26
Peripheral level of CD33 and Alzheimer’s disease: a bidirectional two-sample Mendelian randomization study	26
Polygenic risk scores for major psychiatric and neurodevelopmental disorders contribute to sleep disturbance in childhood: Adolescent Brain Cognitive Development (ABCD) Study	26
Depression treatment response to ketamine: sex-specific role of interleukin-8, but not other inflammatory markers	26
Efficacy and practice of facemask use in general population: a systematic review and meta-analysis	26
Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID-19: an observational multicenter stu	26
Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations	26
Pathological fear, anxiety and negative affect exhibit distinct neurostructural signatures: evidence from psychiatric neuroimaging meta-analysis	26
Fecal microbiota transplantation from patients with rheumatoid arthritis causes depression-like behaviors in mice through abnormal T cells activation	26
Closing the loop between brain and electrical stimulation: towards precision neuromodulation treatments	26
Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy	25
The thalamus and its subnuclei—a gateway to obsessive-compulsive disorder	25
Cerebral small vessel disease burden and longitudinal cognitive decline from age 73 to 82: the Lothian Birth Cohort 1936	25
Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease	25
PTEN in prefrontal cortex is essential in regulating depression-like behaviors in mice	25
Polygenic risk score, healthy lifestyles, and risk of incident depression	25
Parsing variability in borderline personality disorder: a meta-analysis of neuroimaging studies	25
Adverse childhood experiences, daytime salivary cortisol, and depressive symptoms in early adulthood: a longitudinal genetically informed twin study	25
The Sapap3−/− mouse reconsidered as a comorbid model expressing a spectrum of pathological repetitive behaviours	25
Clinical and genetic differences between bipolar disorder type 1 and 2 in multiplex families	25
Differential microRNA expression analyses across two brain regions in Alzheimer’s disease	25
CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and mice	25